Brian Tinmouth
Patrimonio netto: 49 349 $ in data 30/06/2026
Patrimonio netto: 49 349 $ in data 30/06/2026
Brian Philippe Tinmouth is currently an Independent Director at SCYNEXIS, Inc. since 2019.
Formerly, Mr. Tinmouth was Chief Business & Strategy Officer at Mammoth Biosciences, Inc. from 2022 to 2025, Chief Business & Strategy Officer at Pardes Biosciences, Inc. from 2021 to 2022, Vice President & Head-Business Development at Vertex Pharmaceuticals, Inc. from 2013 to 2020, and Senior Manager at Bain & Co., Inc. from 1997 to 2002.
Mr. Tinmouth completed undergraduate studies at Queen's University and earned an MBA from Harvard Business School.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
SCYNEXIS, INC. 0,12% | 26/06/2026 | 12.125 ( 0,12% ) | 49 349 $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| SCYNEXIS, INC. | Direttore/Membro del Consiglio | 13/12/2019 |
| Società | Posizione | Fine |
|---|---|---|
Mammoth Biosciences, Inc.
Mammoth Biosciences, Inc. Internet Software/ServicesTechnology Services Operates CRISPR-based platform for disease detection | Corporate Officer/Principal | 01/02/2025 |
| PARDES BIOSCIENCES, INC. | Corporate Officer/Principal | 30/11/2022 |
| VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | 01/03/2020 |
Bain & Co., Inc.
Bain & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Provides strategy, marketing, organization, operations, IT and M&A consulting services | Corporate Officer/Principal | 01/01/2002 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 7 |
|---|---|
Vertex Pharmaceuticals, Inc.
Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
Bain & Co., Inc.
Bain & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Provides strategy, marketing, organization, operations, IT and M&A consulting services | Commercial Services |
SCYNEXIS, Inc.
SCYNEXIS, Inc. Pharmaceuticals: MajorHealth Technology Develops novel oral and intravenous triterpenoid antifungal for the treatment of several serious fungal infections | Health Technology |
Queen's University
Queen's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Business School
Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mammoth Biosciences, Inc.
Mammoth Biosciences, Inc. Internet Software/ServicesTechnology Services Operates CRISPR-based platform for disease detection | Technology Services |
Pardes Biosciences, Inc.
Pardes Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops oral antiviral treatment for COVID-19 | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale